CANCER: Biomarkers and Targeted Therapy
Closing Date: 12 August 2019
You will be involved in the discovery and development of new prognostic markers to improve prediction of tumour behaviour, host profiling to predict and prevent adverse reactions, or the development of novel biomarkers and targeted therapies. You will have the opportunity to link basic science discoveries with innovative clinical trials and studies.
The Hunter Cancer Research Alliance (HCRA) brings together leading cancer researchers and clinicians from the University of Newcastle, the Hunter Medical Research Institute, the Hunter New England Local Health District and the Calvary Mater Hospital Newcastle. HCRA provides capacity building, funding and strategic support to over 400 members. Cancer research in the Hunter spans the full translational spectrum from basic laboratory science to clinical trials and behavioural, implementation and health services research.
HCRA supports three flagship programs:
1. Biomarkers and Targeted Therapy (BTT)
2. Radiation Oncology, Cancer Imaging & Technology (ROCIT).
3. Implementation Science & Impact (ISI) HCRA is offering one (1) PhD Scholarship under the Biomarkers and Targeted Therapy (BTT) Flagship Program.
For this opportunity, the BTT Flagship Program has six (6) potential projects that the successful candidate can select from.
- Regulation of the response to DNA damaging therapies in breast cancer
- Novel biomarkers for early identification of cancer therapy-induced cardiotoxicity
- Analysis of therapeutic proteins for monitoring immunotherapy treatment of cancer patients
- Neuronal Biomarkers to identify prostate cancers
- Identifying the molecular mechanisms of Glioblastoma response to therapy
- Investigation of the immune system and the tumour microenvironment in glioblastoma
Depending on the project chosen, the respective supervisors are:
1. Dr Kelly Avery Kiejda – Regulation of the response to DNA damaging therapies in breast cancer
2. A/Prof Aaron Sverdlov – Novel biomarkers for early identification of cancer therapy-induced cardiotoxicity
3. Dr Peter Galettis – Analysis of therapeutic proteins for monitoring immunotherapy treatment of cancer patients
4. Prof Hubert Hondermarck – Neuronal Biomarkers to identify prostate cancers
5. Dr Kelly Avery Kiejda - Identifying the molecular mechanisms of Glioblastoma response to therapy
6. A/Prof Paul Tooney – Investigation of the immune system and the tumour microenvironment in glioblastoma
PhD Scholarship details
Funding: $27,596 per annum (2019 rate) indexed annually. For a PhD candidate, the living allowance scholarship is for 3.5 years and the tuition fee scholarship is for four years.
Supervisor: Please see the detailed description above (PhD Scholarship) for the supervisors and their respective projects
Available to: Domestic and International students
The applicant will need to meet the minimum eligibility criteria for admission.
1. If you are interested in working on a PhD project in one of these areas, please send an email introducing yourself to HCRAfirstname.lastname@example.org
2. HCRA will send you research profiles of the potential supervisors. You will be invited to read over these profiles and make contact with the supervisors whose area of research interests you.
3. The supervisor(s) that you have contacted will meet you and assess your suitability to work as part of their team. They may then offer to work with you to prepare a HCRA PhD Application. (NB. Each supervisor has complete discretion when deciding on potential PhD students).
4. The Student (with supervisor approval) submits an application to HCRA-Biomarkers@newcastle.edu.au using the application form provided to the Supervisor.
5. Student/ Supervisor project applications will be assessed by the HCRA Joint Evaluation Committee and the strongest applicant and project combination will be awarded the scholarship.
6. If you have any questions about the PhD Scholarship or the process please contact HCRAemail@example.com or phone 4042 0775.
Please send the email expressing interest to HCRAfirstname.lastname@example.org by 5pm on 12 August 2019.
Applications Close 12 August 2019
|Phone||02 4042 0775|
PhD and Research MastersFind out more